Skip to main content
Byrne Lee, MD, General Surgery, Palo Alto, CA

ByrneLeeMD

General Surgery Palo Alto, CA

Hepatobiliary Surgery, Surgical Oncology (Other than Breast), Minimally Invasive Surgery

Chief, Regional Cancer Therapies

Dr. Lee is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Lee's full profile

Already have an account?

  • Office

    300 Pasteur Dr
    Palo Alto, CA 94305
    Phone+1 650-723-4000
    Fax+1 650-725-3918

Education & Training

  • Zucker School of Medicine at Hofstra/Northwell at Lenox Hill Hospital
    Zucker School of Medicine at Hofstra/Northwell at Lenox Hill HospitalResidency, Surgery, 2000 - 2005
  • New York Medical College
    New York Medical CollegeClass of 2000

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2010 - 2025
  • VA State Medical License
    VA State Medical License 2023 - 2025
  • OR State Medical License
    OR State Medical License 2020 - 2022
  • NY State Medical License
    NY State Medical License 2001 - 2011
  • American Board of Surgery Surgery

Awards, Honors, & Recognition

  • Fellow (FACS) American College of Surgeons

Publications & Presentations

PubMed

Journal Articles

  • Lymphovascular Invasion Predicts Lymph Node Involvement in Small (<2 Cm) Appendiceal Neuroendocrine Tumors  
    Andrew M Blakely, Mustafa Raoof, Byrne Lee, Journal of The American College of Surgeons
  • A Collaborative Surgical Approach to Upper and Lower Abdominal Cytoreductive Surgery in Ovarian Cancer  
    Byrne Lee, Mark T Wakabayashi, Ernest S Han, Thanh H Dellinger, Andrew M Blakely, Bertram Yuh, Journal of Surgical Oncology

Authored Content

  • Lymphovascular Invasion Predicts Lymph Node Involvement in Small (<2 Cm) Appendiceal Neuroendocrine TumorsOctober 2018

Press Mentions

  • HIPEC with Mitomycin C Reduces Locoregional Recurrence in High-Risk Colon Cancer
    HIPEC with Mitomycin C Reduces Locoregional Recurrence in High-Risk Colon CancerApril 26th, 2023
  • OncLive® Presents State of the Science Summit™ on Ovarian Cancer
    OncLive® Presents State of the Science Summit™ on Ovarian CancerJune 17th, 2019

Professional Memberships